Education
University of Virginia School of Law (J.D., 1995) Emory University (B.A., 1990, summa cum laude)Admissions
- District of Columbia
- United States Courts of Appeals for the Fourth, Seventh, Eighth, and Tenth Circuits
- United States District Courts for the Eastern and Western Districts of Arkansas, Northern District of Florida, Central District of Illinois, District of Maryland, Eastern District of Michigan, and Eastern and Western Districts of Virginia
Insights & Events
Third Circuit Agrees with Hollingsworth LLP Amicus Brief in Zoloft Case, Affirming Exclusion of Causation Expert
news | June 2, 2017By Kirby T. Grifffis for Washington Legal Foundation, March 2017
Mr. Griffis shares insights on his most recent victory, including trial tips.
To Tweet or Not to Tweet: How FDA Social Media Guidelines Violate First Amendment
publication | September 25, 2015And The Defense Wins: DRI’s The Voice recognizes Kirby Griffis in win for Novartis.
news | August 26, 2015Partner Kirby T. Griffis represents Novartis in this matter.
St. Louis Federal Jury Returns Verdict for Novartis in Second Zometa Defense Verdict in a Week
news | February 1, 2012Tepid Guidance on a Hot Topic: New York City Bar Ethic Opinion on Litigation Financing
publication | July 22, 2011Washington Legal Foundation's Legal Backgrounder (July 22, 2011) (Kirby T. Griffis)
Cover story for The Metropolitan Corporate Counsel by Firm partner Kirby T. Griffis
MDL court grants Summary Judgment in four first-wave Zometa cases; Case No. 3:08-1157 (Anderson), Case No. 3:08-1156 (Melau), Case No. 3:06-0377 (Thomas).
news | October 28, 2009State court grants motion to dismiss for forum non conveniens to Firm client C.R. Bard, Inc.
news | August 25, 2008LJN's Product Liability Law & Strategy, Vol. 23, No. 3 (September 2004) (Kirby T. Griffis)
LJN's Product Liability Law & Strategy (November/December 2004) (Kirby T. Griffis)
LJN'S Product Liability Law & Strategy, Vol. 22, No. 4 (October 2003) (Kirby T. Griffis)
Cases
Tenth Circuit Unanimously Affirms Plaintiff’s Expert Testimony Not Scientifically Reliable
- Precedent
- Pharmaceutical & Medical Device
- February 14, 2015
The Parlodel Trilogy
- Precedent
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- January 27, 2015
The Zometa Cases
- Precedent
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- Class Action Defense
- January 27, 2015
Louisiana Court of Appeal Overturns Trial Court Judgment for Plaintiff
- Case
- Products Liability & Toxic Torts
- June 17, 2015
Florida Court Dismisses Punitive Damages Claims in Aredia/Zometa Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 16, 2014
S.D. Georgia Grants Novartis Summary Judgment in Zometa Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- May 15, 2013
Novartis Scores Unanimous Defense Verdict from Florida Jury
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- April 9, 2013
Novartis Rebuts Plaintiff’s Changing Failure-to-Warn Theories, Obtaining Summary Judgment on Eve of Trial
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- November 16, 2012
In Major Precedent for Drugmakers, Federal Court Precludes Punitives Under New Jersey Law
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- September 5, 2012
Western District of Oklahoma Grants Summary Judgment in for Novartis
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- July 18, 2012
Southern District of Florida Upholds Removal of a “Pure Bill of Discovery” in Novartis Elidel Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- November 26, 2006
NLJ Top Defense Win for Firm in First Trial of Hernia Repair Mesh Serial Litigation
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 10, 2004